تحميل
NASDAQHealthcareBiotechnology
أحدث البيانات المتاحة
4.84 US$
−0.14 US$ · -2.81%
Champions Oncology, Inc. is dedicated to developing and commercializing cutting-edge technological products and services designed to personalize cancer treatment and streamline the development of oncology drugs across the United States. At the heart of its offerings is the Tumorgraft Technology Platform, an innovative approach that facilitates individualized cancer care by implanting human tumors into immune-deficient mice. Utilizing this proprietary platform, the company not only delivers personalized cancer solutions directly but also provides Translational Oncology Solutions, supporting pharmaceutical and biotechnology companies through their drug development lifecycle. Additionally, Champions Oncology offers Lumin Bioinformatics, a comprehensive software platform and data tool filled with insights from research services and clinical studies, accessible through annual subscriptions. The company distributes its offerings through various channels, including online platforms, word-of-mouth referrals, and a dedicated sales team, reaching both patients and healthcare professionals. Established in 1985, Champions Oncology, Inc. is based in Hackensack, New Jersey, and was formerly known as Champions Biotechnology, Inc. until its name change in April 2011.
الإغلاق السابق
4.84 US$
−0.14 US$ · -2.81%
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
Champions Oncology, Inc. is dedicated to developing and commercializing cutting-edge technological products and services designed to personalize cancer treatment and streamline the development of oncology drugs across the United States. At the heart of its offerings is the Tumorgraft Technology Platform, an innovative approach that facilitates individualized cancer care by implanting human tumors into immune-deficient mice. Utilizing this proprietary platform, the company not only delivers personalized cancer solutions directly but also provides Translational Oncology Solutions, supporting pharmaceutical and biotechnology companies through their drug development lifecycle. Additionally, Champions Oncology offers Lumin Bioinformatics, a comprehensive software platform and data tool filled with insights from research services and clinical studies, accessible through annual subscriptions. The company distributes its offerings through various channels, including online platforms, word-of-mouth referrals, and a dedicated sales team, reaching both patients and healthcare professionals. Established in 1985, Champions Oncology, Inc. is based in Hackensack, New Jersey, and was formerly known as Champions Biotechnology, Inc. until its name change in April 2011.
نطاق اليوم
السعر الحالي 4.84 US$
نطاق 52 أسبوعًا
السعر الحالي 4.84 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
احتفاظ
تقييم
65
أقل من القيمة
المشاعر
40
هبوطي
المخاطر
62
مخاطر مرتفعة
الزخم
32
زخم متراجع
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
Champions Oncology, Inc. is dedicated to developing and commercializing cutting-edge technological products and services designed to personalize cancer treatment and streamline the development of oncology drugs across the United States. At the heart of its offerings is the Tumorgraft Technology Platform, an innovative approach that facilitates individualized cancer care by implanting human tumors into immune-deficient mice. Utilizing this proprietary platform, the company not only delivers personalized cancer solutions directly but also provides Translational Oncology Solutions, supporting pharmaceutical and biotechnology companies through their drug development lifecycle. Additionally, Champions Oncology offers Lumin Bioinformatics, a comprehensive software platform and data tool filled with insights from research services and clinical studies, accessible through annual subscriptions. The company distributes its offerings through various channels, including online platforms, word-of-mouth referrals, and a dedicated sales team, reaching both patients and healthcare professionals. Established in 1985, Champions Oncology, Inc. is based in Hackensack, New Jersey, and was formerly known as Champions Biotechnology, Inc. until its name change in April 2011.
نطاق اليوم
السعر الحالي 4.84 US$
نطاق 52 أسبوعًا
السعر الحالي 4.84 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (USD) | السنة المالية 2026 | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 |
|---|---|---|---|---|---|
| الإيرادات | 59.43 مليون USD | 56.94 مليون USD | 50.16 مليون USD | 53.87 مليون USD | 49.11 مليون USD |
| تكلفة البضاعة المباعة | 30.9 مليون USD | 28.39 مليون USD | 29.4 مليون USD | 29.53 مليون USD | 23.63 مليون USD |
| الربح الإجمالي | 28.53 مليون USD | 28.56 مليون USD | 20.75 مليون USD | 24.34 مليون USD | 25.48 مليون USD |
| البحث والتطوير | 9.08 مليون USD | 6.83 مليون USD | 9.54 مليون USD | 11.55 مليون USD | 9.37 مليون USD |
| مصاريف البيع والمصاريف العمومية والإدارية | 20.47 مليون USD | 16.88 مليون USD | 18.13 مليون USD | 17.24 مليون USD | 15.5 مليون USD |
| نفقات التشغيل | 29.67 مليون USD | 23.71 مليون USD | 27.68 مليون USD | 28.79 مليون USD | 24.87 مليون USD |
| الاستهلاك والإطفاء | 1.38 مليون USD | 1.64 مليون USD | 1.87 مليون USD | 2.25 مليون USD | 1.63 مليون USD |
| الدخل التشغيلي | −1.14 مليون USD | 4.85 مليون USD | −6.92 مليون USD | −4.45 مليون USD | 607 ألف USD |
| صافي الدخل | −1.18 مليون USD | 4.7 مليون USD | −7.28 مليون USD | −5.34 مليون USD | 548 ألف USD |
تم تحديث حقائق الشركة 11 أكتوبر 2026.
أحدث النتائج المعلنة
أحدث النتائج المعلنة
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
صناديق متداولة تفصح عن تعرضها لهذا السهم.
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Extended Market ETFVXF
iShares Micro-Cap ETFIWCالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.
